" class="no-js "lang="en-US"> Oncology Archives - Medtech Alert
Saturday, April 01, 2023

Sort by:


Top Post

NEC Establishes Subsidiaries in Europe for Strengthening Global AI Drug Development Business

NEC Corporation and NOI announced that NOI will be realigned as a subsidiary of NEC […]

Trobix Bio Raises $3 Million from Chartered Group to Advance Precision Microbiome Oncology Therapeutics

Trobix Bio, a company utilizing CRISPR, phage, and synthetic biology technologies to develop advanced precision […]

FDA Issues Draft Guidance Aimed at Improving Oncology Clinical Trials for Accelerated Approval

The United States Food and Drug Administration (FDA) issued draft guidance, Clinical Trial Considerations to […]

Massive Bio and NeoGenomics Announce Collaboration to Accelerate Oncology Drug Discovery and Improve Patient Care

Massive Bio, a private AI-enabled oncology startup that provides virtual and in-person concierge services for […]

Hackensack Meridian Health Invests $14 Million Into Oncology Expansion at JFK University Medical Center

Hackensack Meridian Health is proud to announce it is investing $14 million dollars at JFK […]

Invitae Appoints Dr. W. Michael Korn as Chief Medical Officer for Oncology

Invitae, a leading medical genetics company, has announced the appointment of Dr. W. Michael Korn, […]

Protai Adds $12 Million to Seed Round to Build an Oncology Drug Discovery Pipeline

Protai, a proteomics and AI-powered drug discovery startup revolutionizing the way new drugs are discovered, […]

Debiopharm Extends Their DNA Damage Repair Footprint With New Oncology Pipeline Entry

Debiopharm, an independent Swiss-based, biopharmaceutical company aiming to develop tomorrow’s standard-of-care treatments to cure cancer […]

MEI Pharma and Infinity Pharmaceuticals Announce Definitive Merger Agreement to Advance Three Promising Clinical Oncology Candidates

MEI Pharma, a clinical-stage pharmaceutical company focused on advancing new therapies for cancer, and Infinity […]

Radionetics Oncology Appoints Istvan Molnar, M.D. as Chief Medical Officer

Radionetics Oncology, a pharmaceutical company focused on the discovery and development of novel radiotherapeutics for […]

Vysioneer Announces Data Sharing Agreement with Pfizer to Augment Oncology Clinical Trials with Artificial Intelligence

Vysioneer, a pioneer in AI for Oncology, today announced a data-sharing agreement with Pfizer, a […]

  1. Insmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in Bronchiectasis Read more
  2. NEC Establishes Subsidiaries in Europe for Strengthening Global AI Drug Development Business Read more
  3. Flare Therapeutics Further Strengthens Leadership Team with Key Executive Appointments and Promotions Read more
  4. Sensorion Appoints Khalil Barrage as Interim Chairman of the Board Read more
  5. Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China Read more